ArticleMikrochimica acta2026
Magnetic SERS-based lateral flow immunoassay for ultrasensitive on-site detection of Chikungunya virus in mosquito vectors.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Chikungunya virus (CHIKV) is a significant re-emerging mosquito-borne pathogen primarily transmitted by Aedes aegypti mosquitoes. Its clinical symptoms (e.g., fever and arthralgia) are similar to those of other arboviral infections, frequently leading to misdiagnosis or underdiagnosis in resource-limited areas. Therefore, there is an urgent need for rapid, on-site screening techniques suitable for mosquito vectors to enable early monitoring and warning of arbovirus transmission. To address the inherent challenges of low viral load and complex matrices in mosquito samples, this study developed a lateral flow immunoassay (LFIA) biosensor based on Fe₃O₄@Au magnetic SERS tags. This platform integrates magnetic enrichment with ultrasensitive SERS detection. Driven by an external magnetic field, it enables efficient concentration and purification of trace CHIKV. The assay achieved detection limits (LOD) of 15 pg mL⁻¹ for purified recombinant CHIKV E1 protein and 887 copies mL⁻¹ for inactivated whole virus. Importantly, the platform has been successfully detected CHIKV in field-collected, positive mosquito samples, with results consistent with those from reverse transcription quantitative PCR (RT-qPCR). Collectively, these findings demonstrate the strong potential of this biosensor as a practical tool for the on-site screening and early monitoring of mosquito-borne viruses, providing substantial support for its future application in public health and field surveillance.
Indexed as
Identifiers
41792349What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.